...
机译:P3.16-36佐剂化疗可以通过转移来改善非小细胞肺癌患者的患者的肺癌淋巴结转移。
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Beijing Cancer Hospital;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
Department of Thoracic Surgery Ii Peking University Cancer Hospital and Institute Key Laboratory;
机译:P3.16-36佐剂化疗可以通过转移来改善非小细胞肺癌患者的患者的肺癌淋巴结转移。
机译:遗漏对肺癌患者的成果评估遗漏对没有淋巴结转移的影响:倾向分数匹配分析
机译:遗漏对肺癌患者的成果评估遗漏对没有淋巴结转移的影响:倾向分数匹配分析
机译:F-18-FDG PET / CT诊断非小细胞肺癌(NSCLC)淋巴结转移
机译:基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
机译:N1淋巴结清扫术后辅助化疗可改善非小细胞肺癌伴肺内淋巴结转移的患者预后
机译:感应化学疗法优于诱导化疗,用于病理纵隔淋巴结转移的非小细胞肺癌患者的生存